UNSPSC 51393305: Dexlofexidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VXJ7Z24RN1, chemically known as ( )-(s)-2-(1-(2,6-dichlorophenoxy)ethyl)-2-imidazoline but generally known as dexlofexidine, which bears US NIH Compound Identifier 208822. European Medicines Agency schedules Dexlofexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07035MIG. The term DEXLOFEXIDINE is an International Non-Proprietary Name.

UNSPSC 51393305 Dexlofexidine, a Commodity code, nominally covers a specific pharmaceutical compound, but the recent state and local contract opportunities posted under this code show a mismatch with the code's scope. The solicitations tracked here involve naloxone procurement and pharmacy benefit program administration rather than dexlofexidine itself. State and local health and human services agencies are using this code designation to buy emergency-response pharmaceuticals and to explore direct-to-manufacturer prescription fulfillment models, but the opportunities do not reflect purchases of dexlofexidine specifically.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, requesting information from vendors on direct contracting experience, negotiated net pricing models, and outcomes-based agreement capacity without establishing a formal response deadline or award value at that preliminary stage. The code shows limited recent activity aligned with its pharmaceutical commodity definition, and practitioners should verify whether this code classification reflects actual procurement intent or a taxonomic mislabeling on the part of the issuing jurisdictions.